RP12146

· Rhizen Pharmaceuticals SA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RP12146, covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors [Phase 1]